Answers are grounded in this paper and cite their sources.
Case report shows effective prevention of Clostridioides difficile infection recurrence in a patient with hypogammaglobulinemia, suggesting new treatment strategies.
We present the case of a 57-year-old woman with secondary hypogammaglobulinemia who experienced Clostridioides difficile infection, with repeated recurrences despite transient clinical responses to standard therapies, including repeated fecal microbiota transplantation. Following the replacement of intravenous immunoglobulin supplementation with IgM/IgA-enriched immunoglobulin, no recurrence of CDI was observed during the 24-month follow-up period.
No takes yet. Share an insight, caveat, or question.
Coiffard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: